Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-09

Clinical Trial Update: Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study)

View source ↗

Summary

This clinical trial update notes that the COmPACt study, which investigates cord blood transplantation with myeloablative conditioning and post-transplant cyclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Cord Blood Transplantation, Hematological Malignancies | Status: RECRUITING